Naproxen Tablets, 500 mg
Phase 1Completed 0 watching 0 views this week💤 Quiet
28
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Bioequivalency
Conditions
Bioequivalency
Trial Timeline
Jun 1, 2004 → —
NCT ID
NCT00804401About Naproxen Tablets, 500 mg
Naproxen Tablets, 500 mg is a phase 1 stage product being developed by Perrigo for Bioequivalency. The current trial status is completed. This product is registered under clinical trial identifier NCT00804401. Target conditions include Bioequivalency.
Hype Score Breakdown
Clinical
10
Activity
5
Company
5
Novelty
3
Community
2
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00804401 | Phase 1 | Completed |
| NCT00803764 | Phase 1 | Completed |
Competing Products
3 competing products in Bioequivalency
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Ibuprofen Tablets, 800 mg | Perrigo | Phase 1 | 28 |
| Naproxen Tablets, 500 mg | Perrigo | Phase 1 | 28 |
| Ibuprofen Tablets, 800 mg | Perrigo | Phase 1 | 28 |